Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer

Akira Hirasawa, Issei Imoto, Takuya Naruto, Tomoko Akahane, Wataru Yamagami, Hiroyuki Nomura, Kiyoshi Masuda, Nobuyuki Susumu, Hitoshi Tsuda, Daisuke Aoki

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Pathogenic germline BRCA1, BRCA2 (BRCA1/2), and several other gene variants predispose women to primary ovarian, fallopian tube, and peritoneal carcinoma (OC), although variant frequency and relevance information is scarce in Japanese women with OC. Using targeted panel sequencing, we screened 230 unselected Japanese women with OC from our hospital-based cohort for pathogenic germline variants in 75 or 79 OC-associated genes. Pathogenic variants of 11 genes were identified in 41 (17.8%) women: 19 (8.3%; BRCA1), 8 (3.5%; BRCA2), 6 (2.6%; mismatch repair genes), 3 (1.3%; RAD51D), 2 (0.9%; ATM), 1 (0.4%; MRE11A), 1 (FANCC), and 1 (GABRA6). Carriers of BRCA1/2 or any other tested gene pathogenic variants were more likely to be diagnosed younger, have first or second-degree relatives with OC, and have OC classified as high-grade serous carcinoma (HGSC). After adjustment for these variables, all 3 features were independent predictive factors for pathogenic variants in any tested genes whereas only the latter two remained for variants in BRCA1/2. Our data indicate similar variant prevalence in Japanese patients with OC and other ethnic groups and suggest that HGSC and OC family history may facilitate genetic predisposition prediction in Japanese patients with OC and referring high-risk patients for genetic counseling and testing.

Original languageEnglish
Pages (from-to)112258-112267
Number of pages10
JournalOncotarget
Volume8
Issue number68
DOIs
Publication statusPublished - Jan 1 2017
Externally publishedYes

Fingerprint

Ovarian Neoplasms
Genes
Carcinoma
DNA Mismatch Repair
Fallopian Tubes
Genetic Counseling
Genetic Testing
Genetic Predisposition to Disease
Ethnic Groups

Keywords

  • Germline
  • Japanese women
  • Multigene panel
  • Ovarian cancer
  • Pathogenic variant

ASJC Scopus subject areas

  • Oncology

Cite this

Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer. / Hirasawa, Akira; Imoto, Issei; Naruto, Takuya; Akahane, Tomoko; Yamagami, Wataru; Nomura, Hiroyuki; Masuda, Kiyoshi; Susumu, Nobuyuki; Tsuda, Hitoshi; Aoki, Daisuke.

In: Oncotarget, Vol. 8, No. 68, 01.01.2017, p. 112258-112267.

Research output: Contribution to journalArticle

Hirasawa, A, Imoto, I, Naruto, T, Akahane, T, Yamagami, W, Nomura, H, Masuda, K, Susumu, N, Tsuda, H & Aoki, D 2017, 'Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer', Oncotarget, vol. 8, no. 68, pp. 112258-112267. https://doi.org/10.18632/oncotarget.22733
Hirasawa, Akira ; Imoto, Issei ; Naruto, Takuya ; Akahane, Tomoko ; Yamagami, Wataru ; Nomura, Hiroyuki ; Masuda, Kiyoshi ; Susumu, Nobuyuki ; Tsuda, Hitoshi ; Aoki, Daisuke. / Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer. In: Oncotarget. 2017 ; Vol. 8, No. 68. pp. 112258-112267.
@article{1f1b5bf464974b8585b723e1d366b454,
title = "Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer",
abstract = "Pathogenic germline BRCA1, BRCA2 (BRCA1/2), and several other gene variants predispose women to primary ovarian, fallopian tube, and peritoneal carcinoma (OC), although variant frequency and relevance information is scarce in Japanese women with OC. Using targeted panel sequencing, we screened 230 unselected Japanese women with OC from our hospital-based cohort for pathogenic germline variants in 75 or 79 OC-associated genes. Pathogenic variants of 11 genes were identified in 41 (17.8{\%}) women: 19 (8.3{\%}; BRCA1), 8 (3.5{\%}; BRCA2), 6 (2.6{\%}; mismatch repair genes), 3 (1.3{\%}; RAD51D), 2 (0.9{\%}; ATM), 1 (0.4{\%}; MRE11A), 1 (FANCC), and 1 (GABRA6). Carriers of BRCA1/2 or any other tested gene pathogenic variants were more likely to be diagnosed younger, have first or second-degree relatives with OC, and have OC classified as high-grade serous carcinoma (HGSC). After adjustment for these variables, all 3 features were independent predictive factors for pathogenic variants in any tested genes whereas only the latter two remained for variants in BRCA1/2. Our data indicate similar variant prevalence in Japanese patients with OC and other ethnic groups and suggest that HGSC and OC family history may facilitate genetic predisposition prediction in Japanese patients with OC and referring high-risk patients for genetic counseling and testing.",
keywords = "Germline, Japanese women, Multigene panel, Ovarian cancer, Pathogenic variant",
author = "Akira Hirasawa and Issei Imoto and Takuya Naruto and Tomoko Akahane and Wataru Yamagami and Hiroyuki Nomura and Kiyoshi Masuda and Nobuyuki Susumu and Hitoshi Tsuda and Daisuke Aoki",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.22733",
language = "English",
volume = "8",
pages = "112258--112267",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "68",

}

TY - JOUR

T1 - Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer

AU - Hirasawa, Akira

AU - Imoto, Issei

AU - Naruto, Takuya

AU - Akahane, Tomoko

AU - Yamagami, Wataru

AU - Nomura, Hiroyuki

AU - Masuda, Kiyoshi

AU - Susumu, Nobuyuki

AU - Tsuda, Hitoshi

AU - Aoki, Daisuke

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Pathogenic germline BRCA1, BRCA2 (BRCA1/2), and several other gene variants predispose women to primary ovarian, fallopian tube, and peritoneal carcinoma (OC), although variant frequency and relevance information is scarce in Japanese women with OC. Using targeted panel sequencing, we screened 230 unselected Japanese women with OC from our hospital-based cohort for pathogenic germline variants in 75 or 79 OC-associated genes. Pathogenic variants of 11 genes were identified in 41 (17.8%) women: 19 (8.3%; BRCA1), 8 (3.5%; BRCA2), 6 (2.6%; mismatch repair genes), 3 (1.3%; RAD51D), 2 (0.9%; ATM), 1 (0.4%; MRE11A), 1 (FANCC), and 1 (GABRA6). Carriers of BRCA1/2 or any other tested gene pathogenic variants were more likely to be diagnosed younger, have first or second-degree relatives with OC, and have OC classified as high-grade serous carcinoma (HGSC). After adjustment for these variables, all 3 features were independent predictive factors for pathogenic variants in any tested genes whereas only the latter two remained for variants in BRCA1/2. Our data indicate similar variant prevalence in Japanese patients with OC and other ethnic groups and suggest that HGSC and OC family history may facilitate genetic predisposition prediction in Japanese patients with OC and referring high-risk patients for genetic counseling and testing.

AB - Pathogenic germline BRCA1, BRCA2 (BRCA1/2), and several other gene variants predispose women to primary ovarian, fallopian tube, and peritoneal carcinoma (OC), although variant frequency and relevance information is scarce in Japanese women with OC. Using targeted panel sequencing, we screened 230 unselected Japanese women with OC from our hospital-based cohort for pathogenic germline variants in 75 or 79 OC-associated genes. Pathogenic variants of 11 genes were identified in 41 (17.8%) women: 19 (8.3%; BRCA1), 8 (3.5%; BRCA2), 6 (2.6%; mismatch repair genes), 3 (1.3%; RAD51D), 2 (0.9%; ATM), 1 (0.4%; MRE11A), 1 (FANCC), and 1 (GABRA6). Carriers of BRCA1/2 or any other tested gene pathogenic variants were more likely to be diagnosed younger, have first or second-degree relatives with OC, and have OC classified as high-grade serous carcinoma (HGSC). After adjustment for these variables, all 3 features were independent predictive factors for pathogenic variants in any tested genes whereas only the latter two remained for variants in BRCA1/2. Our data indicate similar variant prevalence in Japanese patients with OC and other ethnic groups and suggest that HGSC and OC family history may facilitate genetic predisposition prediction in Japanese patients with OC and referring high-risk patients for genetic counseling and testing.

KW - Germline

KW - Japanese women

KW - Multigene panel

KW - Ovarian cancer

KW - Pathogenic variant

UR - http://www.scopus.com/inward/record.url?scp=85038855287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038855287&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.22733

DO - 10.18632/oncotarget.22733

M3 - Article

VL - 8

SP - 112258

EP - 112267

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 68

ER -